A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
2006

Producing a Key Protein for Antiphospholipid Syndrome in Bacteria

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Ioannou Yiannis, Giles Ian, Lambrianides Anastasia, Richardson Chris, Pearl Laurence H, Latchman David S, Isenberg David A, Rahman Anisur

Primary Institution: University College London

Hypothesis

We hypothesise that the challenges in expressing domain I of human beta2 glycoprotein I in E. coli are related to codon bias, potential toxicity, and disulphide bond formation difficulties.

Conclusion

Efficient, soluble expression of the eukaryotic protein domain I of beta2 glycoprotein I in E. coli is achievable, which may aid future antigenic studies and therapeutic applications.

Supporting Evidence

  • The study achieved yields of 750 μg/L of the target protein.
  • Recombinant DI was shown to bind human monoclonal antiphospholipid antibodies.
  • The expression system allowed for the production of conformationally correct DI.

Takeaway

Scientists figured out how to make a special protein in bacteria that can help understand a disease that causes blood clots and miscarriages.

Methodology

The study used a synthetic gene designed for E. coli expression, followed by recursive PCR and tight regulation of expression using the T7lac promoter.

Limitations

The study does not address potential post-translational modifications that may be necessary for the protein's biological activity.

Participant Demographics

The study involved 21 patients with antiphospholipid syndrome, 14 patients with systemic lupus erythematosus, and 9 healthy controls.

Statistical Information

P-Value

p<0.005

Statistical Significance

p<0.005

Digital Object Identifier (DOI)

10.1186/1472-6750-6-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication